
    
      This is a prospective randomized study including 70 diabetes with coronary disease patients
      that needed to be submitted to oral surgery. The study was double blind in relation to
      glycaemia measurements. Continuous monitoring of blood glucose levels for 24 hours was
      performed using the Minimed Continuous Monitoring System (CGMS, Medtronic). Patientes were
      randomized into two groups: 35 received 5.4 mL of 2% lidocaine and 35 received 5.4 mL of 2%
      lidocaine with 1:100,000 epinephrine. In addittion, hemodynamic effects (blood pressure and
      heart rate) and degree of anxiety were also evaluated.
    
  